Summa Health Network, LLC Improves Screening Rates For Diabetic Retinopathy with Emmi Solutions Technology

Summa Health Network, LLC Improves Screening Rates For Diabetic Retinopathy with Emmi Solutions Technology

<0> Emmi Solutions, LLCTodd Medland, 312.448.5842 </0>

Summa Health Network, LLC, a physician-hospital organization representing more than 1,400 physicians throughout (one of the largest integrated healthcare delivery systems in Ohio), significantly increased screening rates for diabetic retinopathy by implementing Emmi Solutions’ patient communications program called ®. This data has been selected for a poster presentation at the , taking place July 25-27 in San Diego.

Diabetic retinopathy is a leading complication and cause of blindness for people with diabetes, and diabetic eye screenings can prevent 90 percent of patients from progressing to serious vision loss. Summa teamed up with Emmi Solutions, the leader in outcomes-driven patient engagement, to launch a pilot project to help improve the number of diabetic eye exam results on file for a small number of patients in Ohio Family Practice, part of Summa Health Network. The issue was either a patient had the eye exam but it wasn’t documented, or a patient never had the eye exam.

"Many diabetic patients go without the screening and are not aware of the risk of diabetic retinopathy that affects nearly half of people with diabetes,” said James Dom Dera, M.D., medical director of Summa’s accountable care organization (ACO), New Health Collaborative and a physician with Ohio Family Practice. “By implementing Emmi’s patient communications tools, we’re better able to educate our patients and reach out to them in an interactive and personal way via phone – which has significantly improved clinical and population health outcomes and the efficiency of our practice.”

This initiative proved to be cost effective and produced tremendous results.

Even though the initial program rollout was limited to a small population of patients at Ohio Family Practice, Summa improved its HEDIS (Healthcare Effectiveness Data and Information Set) score for diabetic eye exams by 13 percent in only six weeks. Since the pilot project of managing a population’s health using EmmiPrevent has been so successful, Summa has expanded the campaign to 13 of its practices.

Summa is also planning future call campaigns focused on preventive and disease management measures such as the hemoglobin A1C test, which measures diabetic patients’ average blood glucose level over two to three months; mammography, colorectal cancer screening and hypertension screening.

Emmi’s proprietary interactive communication methodology delivers actionable health information to patients via multiple modalities – including computers, mobile phones and tablets – at key moments across the continuum of care. Emmi’s ability to connect with patients in language they understand at a time they are ready to learn and through the devices they already own has been demonstrated to help healthcare providers reduce costs, increase revenue and improve outcomes. The patented platform allows providers to track the delivery and consumption of information to measure the clinical and financial impact of patient engagement and meet regulatory guidelines. The web-based platform requires no installation or maintenance and can be used in stand-alone mode or fully integrated into existing systems. Learn more by visiting  or find us on or .

Summa Health System is one of the largest integrated healthcare delivery systems in Ohio. Encompassing a network of hospitals, community health centers, a health plan, a physician-hospital organization, a multi-specialty physician organization, research and multiple foundations, Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery. Summa's clinical services are consistently recognized by the American Nurses Credentialing Center (Magnet status), , Thomson Reuters and The Leapfrog Group. Summa also is a founding partner of the Austen BioInnovation Institute in Akron. For more information, visit  or find us on Facebook at  and Twitter at .